Promoter Essix Biosciences acquires 51 lakh shares via warrant conversion
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoter Essix Biosciences Limited acquired 51,00,000 equity shares of Ind-Swift Laboratories on Feb 24, 2026, by converting fully convertible warrants into equity shares at Rs. 121 each (about Rs. 61.71 crore total). Essix Biosciences stake rose from 34.04% to 37.92% of post-issue share capital. Total promoter and promoter group holding now stands at 43.06% (40.05% on a fully diluted basis).
Signals promoter confidence in the company. No fresh cash from public markets since shares came via warrant conversion. Promoter group holding strengthens to 43.06%.